NO331018B1 - In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning - Google Patents

In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning

Info

Publication number
NO331018B1
NO331018B1 NO20015157A NO20015157A NO331018B1 NO 331018 B1 NO331018 B1 NO 331018B1 NO 20015157 A NO20015157 A NO 20015157A NO 20015157 A NO20015157 A NO 20015157A NO 331018 B1 NO331018 B1 NO 331018B1
Authority
NO
Norway
Prior art keywords
neoplastic
mammals
kit
screening
determination
Prior art date
Application number
NO20015157A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015157D0 (no
NO20015157L (no
Inventor
Michael Slater
Julian Alexander Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Publication of NO20015157D0 publication Critical patent/NO20015157D0/no
Publication of NO20015157L publication Critical patent/NO20015157L/no
Publication of NO331018B1 publication Critical patent/NO331018B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20015157A 1999-04-21 2001-10-22 In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning NO331018B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (3)

Publication Number Publication Date
NO20015157D0 NO20015157D0 (no) 2001-10-22
NO20015157L NO20015157L (no) 2001-12-21
NO331018B1 true NO331018B1 (no) 2011-09-12

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015157A NO331018B1 (no) 1999-04-21 2001-10-22 In vitro fremgangsmate ved bestemmelse av pre-neoplastiske og/eller neoplastiske tilstander hos pattedyr ved purinergisk reseptorekspresjon, samt anvendelse og sett for slik pavisning

Country Status (14)

Country Link
US (3) US7183064B1 (de)
EP (1) EP1179183B1 (de)
JP (1) JP4633984B2 (de)
KR (1) KR100819395B1 (de)
CN (1) CN100557445C (de)
AT (1) ATE456799T1 (de)
AU (2) AUPP991199A0 (de)
CA (1) CA2371163A1 (de)
DE (1) DE60043775D1 (de)
DK (1) DK1179183T3 (de)
ES (1) ES2340137T3 (de)
NO (1) NO331018B1 (de)
WO (1) WO2001006259A1 (de)
ZA (1) ZA200108616B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CN101555283B (zh) * 2001-01-17 2012-03-21 生物权威国际有限公司 针对非功能性p2x7受体的抗体及其在癌症和其它病情的诊断和治疗中的用途
WO2008043145A1 (en) * 2006-10-10 2008-04-17 Biosceptre International Limited Hybridomas producing antibodies against non functional p2x7 receptor
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
JP5670192B2 (ja) 2007-09-14 2015-02-18 バイオセプター・インターナショナル・リミテッド 新規ｐ２ｘ７エピトープ
WO2009033234A1 (en) * 2007-09-14 2009-03-19 Biosceptre International Limited Purinergic (p2x) receptors in extra-cellular body fluid
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
CA2747644C (en) * 2008-12-19 2023-01-24 Ablynx N.V. Method for generation of immunoglobulin sequences
EP3395832B1 (de) 2009-08-20 2021-11-24 Biosceptre (Aust) Pty Ltd Anti-p2x7-rezeptor-antikörper und fragmente davon
EP2516470B1 (de) 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antikörper gegen nichtfunktionelle oligomere p2x7-rezeptoren
WO2012031333A1 (en) 2010-09-10 2012-03-15 Biosceptre International Limited Companion animal treatments
WO2013003895A1 (en) 2011-07-01 2013-01-10 Biosceptre International Limited Combination therapy
ES2899754T3 (es) * 2014-05-02 2022-03-14 Medimmune Ltd Moduladores de canales iónicos y usos de los mismos
US12121539B2 (en) 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
CN109862883A (zh) 2016-10-21 2019-06-07 生物权威（英国）有限公司 细胞毒性颗粒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
EP0760850A1 (de) 1994-05-27 1997-03-12 Glaxo Group Limited P2x REZEPTOREN (PURINOCEPTORENFAMILIE)
US5981218A (en) * 1995-08-09 1999-11-09 Bristol-Myers Squibb Company Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis and encoded polypeptides
JP2001521372A (ja) * 1996-04-30 2001-11-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ヒトＰ２ｘ４レセプタースプライス−変異体
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CN101555283B (zh) * 2001-01-17 2012-03-21 生物权威国际有限公司 针对非功能性p2x7受体的抗体及其在癌症和其它病情的诊断和治疗中的用途

Also Published As

Publication number Publication date
WO2001006259A1 (en) 2001-01-25
DE60043775D1 (de) 2010-03-18
US20070248963A1 (en) 2007-10-25
ATE456799T1 (de) 2010-02-15
EP1179183B1 (de) 2010-01-27
JP2003504643A (ja) 2003-02-04
CN100557445C (zh) 2009-11-04
CA2371163A1 (en) 2001-01-25
AU3949000A (en) 2001-02-05
US7183064B1 (en) 2007-02-27
HK1044190A1 (en) 2002-10-11
AU779845B2 (en) 2005-02-17
KR100819395B1 (ko) 2008-04-04
KR20020022651A (ko) 2002-03-27
EP1179183A1 (de) 2002-02-13
NO20015157D0 (no) 2001-10-22
ZA200108616B (en) 2002-06-13
US20110111431A1 (en) 2011-05-12
NO20015157L (no) 2001-12-21
ES2340137T3 (es) 2010-05-31
AUPP991199A0 (en) 1999-05-13
EP1179183A4 (de) 2003-01-22
DK1179183T3 (da) 2010-05-25
CN1355886A (zh) 2002-06-26
JP4633984B2 (ja) 2011-02-16

Similar Documents

Publication Publication Date Title
NO20015157D0 (no) Fremgangsmåte ved bestemmelse av pre-noeplastiske og/eller neoplastiske tilstander hos pattedyr
BRPI9912227B1 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
AU2001268449A1 (en) Toxicity typing using liver stem cells
EP0915173A3 (de) Reagentiensatz und Verfahren für Fluoreszenzerkennungstest
ATE424560T1 (de) Marker für neuromyelitis optica
WO2005052542A3 (en) Method and composition useful for determining fk 506
WO2003047420A3 (en) Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
BRPI0410261A (pt) método de detecção de probnp natural
AU7709198A (en) Low background multi-well plates for fluorescence measurements of biological andbiochemical samples
EP1352085A4 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
WO1999025843A3 (en) Human checkpoint kinase, hcds1, compositions and methods
BR9703386A (pt) Células aviárias imortalizadas
ES2175116T3 (es) Metodos para determinar el genotipo del color del pelaje de un cerdo.
DE69626639D1 (de) Phycobilisome, derivate und ihre verwendung
BR0110603A (pt) Couro natural revestido com poliuretano e método de preparação de couro natural revestido
DK1247101T3 (da) Transferrin-assay
EP1108212A4 (de) Verfahren und materialien zur diagnose instabiler angina
BR0215452A (pt) Teste de proteìna tirosina-fosfatase (ptpase) altamente sensitivo com o emprego de 6,8-diflúor-4-metil-umbeliferilfosfato
AU8904598A (en) Methods, kits, electrodes and compositions for assessing the level of an analyteof interest in fluid samples
D'Agostino Šumerskij Jazyk
WO2006023211A3 (en) Antigens targeted by pathogenic ai4 t cells in type 1 diabetes and uses thereof
NO964803D0 (no) Fremgangsmåte for måling av konsentrasjonen av glykoler/polyglykoler i fluiden, måleinstrument samt analysesett
WO2001004305A3 (en) Human proteins involved in detoxification
WO2004048518A3 (en) Organelle-associated proteins

Legal Events

Date Code Title Description
MK1K Patent expired